|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/12 | (2006.01) |
| C07D 401/12 | (2013.01) | ||
| C07D 403/12 | (2006.01) | ||
| C07D 403/12 | (2013.01) | ||
| A61P 29/00 | (2006.01) | ||
| A61P 37/00 | (2018.01) | ||
| A61P 37/00 | (2006.01) | ||
| A61P 29/00 | (2018.01) | ||
| A61K 31/4439 | (2006.01) | ||
| A61K 31/501 | (2006.01) |
| (11) | Number of the document | 3999499 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20753523.8 |
| Date of filing the European patent application | 2020-07-14 | |
| (97) | Date of publication of the European application | 2022-05-25 |
| (45) | Date of publication and mention of the grant of the patent | 2024-09-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2020/041876 |
| Date | 2020-07-14 |
| (87) | Number | WO 2021/011513 |
| Date | 2021-01-21 |
| (30) | Number | Date | Country code |
| 201962874531 P | 2019-07-16 | US |
| (72) |
MOSLIN, Ryan M. , US
WEINSTEIN, David S. , US
RAMAR, Thangeswaran , IN
ANDAPPAN MURUGAIAH SUBBAIAH, Murugaiah , IN
|
| (73) |
Bristol-Myers Squibb Company ,
Route 206 and Province Line Road, Princeton, NJ 08543,
US
|
| (54) | PRODRUGS IN THE MODULATION OF INTERLEUKIN |
| PRODRUGS IN THE MODULATION OF INTERLEUKIN |